BRCA1 and breast cancer: We report for the first time the use of quantitative breast cancer risk assessment for use in enrollment in a breast cancer screening pilot study by combining both the established Gail model and a purely genetic model which estimates BRCA1/2 mutation risk via BRCAPRO.